FindMyKOL
Clinical trialNCT00353067SuspendedPhase 3Interventional

Veliflapon (DG-031)to Prevent Heart Attacks or Stroke in Patients With a History of Heart Attack or Unstable Angina

SponsordeCODE geneticsEnrollment3,450Acute Coronary Syndrome
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to determine if veliflapon (DG-031)can prevent a heart attack or stroke in African American patients with a history of unstable angina or myocardial infarction.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Facility name not stated

    Montgomery, Alabama, United States

  • Facility name not stated

    Jacksonville, Florida, United States

  • Facility name not stated

    Melrose Park, Illinois, United States

  • Facility name not stated

    Oklahoma City, Oklahoma, United States

  • Facility name not stated

    Philadelphia, Pennsylvania, United States

  • Facility name not stated

    Nashville, Tennessee, United States

  • Facility name not stated

    Carrollton, Texas, United States

  • Facility name not stated

    Fort Worth, Texas, United States

  • Facility name not stated

    Richardson, Texas, United States

  • Facility name not stated

    Hopewell, Virginia, United States

  • Facility name not stated

    Suffolk, Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Veliflapon
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 May 2006
Primary completion
—
Completion
—
Last update posted
29 Nov 2006
Registered enrollment
3,450
Registry id
NCT00353067
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.